Tapewire

Nasdaq · USD

CYTK

CYTOKINETICS INC

Export transactions ↓
Tapewire entity
3528
SEC CIK
0001061983
Parsed reports
875

Last 12 months

Inside the activity.

0 purchase rows · 83 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 202509
Jan 202603
Feb 202602
Mar 2026017
Apr 202608
May 202609
Jun 202608
Jul 202609
Aug 202604
Sep 202608
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 10, 2022 Filed May 11, 2022 22:07 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $37.89 $0.00
Disclosure

SEC source: 0001061983-22-000123 · edgardoc.xml · derivative · entry 2

Wysenski Nancy · CIK 0001294596 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2032-05-10

F2 · derivative.exercise_date: Options shall vest and become exercisable in 12 equal monthly installments, the first such installment vesting on 06/10/2022 and the last such installment vesting on 05/10/2023.

Read SEC document
May 10, 2022 Filed May 11, 2022 22:07 UTC GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001061983-22-000123 · edgardoc.xml · nonDerivative · entry 1

Wysenski Nancy · CIK 0001294596 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,149

F1 · kind: Comprised of restricted stock units that will vest in full and in one installment on 05/10/2023.

Read SEC document
May 10, 2022 Filed May 11, 2022 22:07 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $37.89 $0.00
Disclosure

SEC source: 0001061983-22-000122 · edgardoc.xml · derivative · entry 2

WIERENGA WENDALL · CIK 0001235945 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2032-05-10

F2 · derivative.exercise_date: Options shall vest and become exercisable in 12 equal monthly installments, the first such installment vesting on 06/10/2022 and the last such installment vesting on 05/10/2023.

Read SEC document
May 10, 2022 Filed May 11, 2022 22:07 UTC GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001061983-22-000122 · edgardoc.xml · nonDerivative · entry 1

WIERENGA WENDALL · CIK 0001235945 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,033

F1 · kind: Comprised of restricted stock units that will vest in full and in one installment on 05/10/2023.

Read SEC document
May 10, 2022 Filed May 11, 2022 22:06 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $37.89 $0.00
Disclosure

SEC source: 0001061983-22-000121 · edgardoc.xml · derivative · entry 2

SMITH SANDFORD D · CIK 0001243004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2032-05-10

F2 · derivative.exercise_date: Options shall vest and become exercisable in 12 equal monthly installments, the first such installment vesting on 06/10/2022 and the last such installment vesting on 05/10/2023.

Read SEC document
May 10, 2022 Filed May 11, 2022 22:06 UTC GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001061983-22-000121 · edgardoc.xml · nonDerivative · entry 1

SMITH SANDFORD D · CIK 0001243004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,033

F1 · kind: Comprised of restricted stock units that will vest in full and in one installment on 05/10/2023.

Read SEC document
May 10, 2022 Filed May 11, 2022 22:05 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $37.89 $0.00
Disclosure

SEC source: 0001061983-22-000119 · edgardoc.xml · derivative · entry 2

Kaye Edward M. MD · CIK 0001522780 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2032-05-10

F2 · derivative.exercise_date: Options shall vest and become exercisable in 12 equal monthly installments, the first such installment vesting on 06/10/2022 and the last such installment vesting on 05/10/2023.

Read SEC document
May 10, 2022 Filed May 11, 2022 22:05 UTC GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001061983-22-000119 · edgardoc.xml · nonDerivative · entry 1

Kaye Edward M. MD · CIK 0001522780 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,302

F1 · kind: Comprised of restricted stock units that will vest in full and in one installment on 05/10/2023.

Read SEC document
May 10, 2022 Filed May 11, 2022 22:05 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $37.89 $0.00
Disclosure

SEC source: 0001061983-22-000118 · edgardoc.xml · derivative · entry 3

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2032-05-10

F2 · derivative.exercise_date: Options shall vest and become exercisable in 12 equal monthly installments, the first such installment vesting on 06/10/2022 and the last such installment vesting on 05/10/2023.

Read SEC document
May 10, 2022 Filed May 11, 2022 22:05 UTC GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001061983-22-000118 · edgardoc.xml · nonDerivative · entry 1

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,562

F1 · kind: Comprised of restricted stock units that will vest in full and in one installment on 05/10/2023.

Read SEC document
May 10, 2022 Filed May 11, 2022 22:05 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $37.89 $0.00
Disclosure

SEC source: 0001061983-22-000117 · edgardoc.xml · derivative · entry 2

Harrington Robert Arthur · CIK 0001923988 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2032-05-10

F2 · derivative.exercise_date: Options shall vest and become exercisable in 12 equal monthly installments, the first such installment vesting on 06/10/2022 and the last such installment vesting on 05/10/2023.

Read SEC document
May 10, 2022 Filed May 11, 2022 22:05 UTC GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001061983-22-000117 · edgardoc.xml · nonDerivative · entry 1

Harrington Robert Arthur · CIK 0001923988 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

F1 · kind: Comprised of restricted stock units that will vest in full and in one installment on 05/10/2023.

Read SEC document
May 10, 2022 Filed May 11, 2022 22:04 UTC
Bhanji MunaDirector
GrantNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $37.89 $0.00
Disclosure

SEC source: 0001061983-22-000115 · edgardoc.xml · derivative · entry 2

Bhanji Muna · CIK 0001846905 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2032-05-10

F2 · derivative.exercise_date: Options shall vest and become exercisable in 12 equal monthly installments, the first such installment vesting on 06/10/2022 and the last such installment vesting on 05/10/2023.

Read SEC document
May 10, 2022 Filed May 11, 2022 22:04 UTC
Bhanji MunaDirector
GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001061983-22-000115 · edgardoc.xml · nonDerivative · entry 1

Bhanji Muna · CIK 0001846905 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,537

F1 · kind: Comprised of restricted stock units that will vest in full and in one installment on 05/10/2023.

Read SEC document
May 04, 2022 Filed May 6, 2022 20:31 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $7.96 $0.00
Disclosure

SEC source: 0001061983-22-000105 · edgardoc.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,208

Underlying: Common Stock · 10,000 shares

Expires 2025-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
May 04, 2022 Filed May 6, 2022 20:31 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 10,000 $39.43 $394,321.00
Disclosure

SEC source: 0001061983-22-000105 · edgardoc.xml · nonDerivative · entry 2

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 409,124

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
May 04, 2022 Filed May 6, 2022 20:31 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 10,000 $7.96 $79,600.00
Disclosure

SEC source: 0001061983-22-000105 · edgardoc.xml · nonDerivative · entry 1

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 419,124

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
April 20, 2022 Filed Apr 22, 2022 20:15 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $7.96 $0.00
Disclosure

SEC source: 0001061983-22-000103 · edgardoc.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,208

Underlying: Common Stock · 10,000 shares

Expires 2025-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
April 20, 2022 Filed Apr 22, 2022 20:15 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 10,000 $37.89 $378,867.00
Disclosure

SEC source: 0001061983-22-000103 · edgardoc.xml · nonDerivative · entry 2

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 409,124

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
April 20, 2022 Filed Apr 22, 2022 20:15 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 10,000 $7.96 $79,600.00
Disclosure

SEC source: 0001061983-22-000103 · edgardoc.xml · nonDerivative · entry 1

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 419,124

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
April 08, 2022 Filed Apr 19, 2022 01:22 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 35,000 $41.69 Strike: $41.69 $1,459,150.00
Disclosure

SEC source: 0001061983-22-000101 · edgardoc.xml · derivative · entry 1

Harrington Robert Arthur · CIK 0001923988 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2032-04-08

F1 · derivative.exercise_date: Options shall vest and become exercisable in 36 equal monthly installments as from the date of the grant.

Read SEC document
April 07, 2022 Filed Apr 7, 2022 21:21 UTC
Malik Fady IbrahamEVP Research & Development
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 23,148 $0.00 Strike: $6.00 $0.00
Disclosure

SEC source: 0001061983-22-000097 · edgardoc.xml · derivative · entry 3

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,148 shares

Expires 2023-03-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
April 07, 2022 Filed Apr 7, 2022 21:21 UTC
Malik Fady IbrahamEVP Research & Development
SaleCommon Stock 23,148 $42.58 $985,755.27
Disclosure

SEC source: 0001061983-22-000097 · edgardoc.xml · nonDerivative · entry 2

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,084

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
April 07, 2022 Filed Apr 7, 2022 21:21 UTC
Malik Fady IbrahamEVP Research & Development
Exercise / conversionCommon Stock 23,148 $6.00 $138,888.00
Disclosure

SEC source: 0001061983-22-000097 · edgardoc.xml · nonDerivative · entry 1

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 191,232

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
April 05, 2022 Filed Apr 6, 2022 23:12 UTC
Jaw ChingSVP Finance & CFO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $12.10 $0.00
Disclosure

SEC source: 0001061983-22-000095 · edgardoc.xml · derivative · entry 6

Jaw Ching · CIK 0001710875 · SVP Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,944

Underlying: Common Stock · 10,000 shares

Expires 2027-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
April 05, 2022 Filed Apr 6, 2022 23:12 UTC
Jaw ChingSVP Finance & CFO
SaleCommon Stock 10,000 $42.00 $420,000.00
Disclosure

SEC source: 0001061983-22-000095 · edgardoc.xml · nonDerivative · entry 4

Jaw Ching · CIK 0001710875 · SVP Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,109

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
April 05, 2022 Filed Apr 6, 2022 23:12 UTC
Jaw ChingSVP Finance & CFO
Exercise / conversionCommon Stock 10,000 $12.10 $121,000.00
Disclosure

SEC source: 0001061983-22-000095 · edgardoc.xml · nonDerivative · entry 3

Jaw Ching · CIK 0001710875 · SVP Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,109

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
April 04, 2022 Filed Apr 6, 2022 23:12 UTC
Jaw ChingSVP Finance & CFO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 15,000 $0.00 Strike: $12.10 $0.00
Disclosure

SEC source: 0001061983-22-000095 · edgardoc.xml · derivative · entry 5

Jaw Ching · CIK 0001710875 · SVP Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,944

Underlying: Common Stock · 15,000 shares

Expires 2027-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
April 04, 2022 Filed Apr 6, 2022 23:12 UTC
Jaw ChingSVP Finance & CFO
SaleCommon Stock 15,000 $40.00 $600,000.00
Disclosure

SEC source: 0001061983-22-000095 · edgardoc.xml · nonDerivative · entry 2

Jaw Ching · CIK 0001710875 · SVP Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,109

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
April 04, 2022 Filed Apr 6, 2022 23:12 UTC
Jaw ChingSVP Finance & CFO
Exercise / conversionCommon Stock 15,000 $12.10 $181,500.00
Disclosure

SEC source: 0001061983-22-000095 · edgardoc.xml · nonDerivative · entry 1

Jaw Ching · CIK 0001710875 · SVP Finance & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,109

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
April 04, 2022 Filed Apr 6, 2022 23:11 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $7.96 $0.00
Disclosure

SEC source: 0001061983-22-000094 · edgardoc.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139,208

Underlying: Common Stock · 10,000 shares

Expires 2025-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
April 04, 2022 Filed Apr 6, 2022 23:11 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 10,000 $38.78 $387,834.00
Disclosure

SEC source: 0001061983-22-000094 · edgardoc.xml · nonDerivative · entry 2

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 409,124

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
April 04, 2022 Filed Apr 6, 2022 23:11 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 10,000 $7.96 $79,600.00
Disclosure

SEC source: 0001061983-22-000094 · edgardoc.xml · nonDerivative · entry 1

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 419,124

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
April 01, 2022 Filed Apr 1, 2022 23:17 UTC GrantCommon Stock 293 $38.38 $11,245.34
Disclosure

SEC source: 0001061983-22-000088 · edgardoc.xml · nonDerivative · entry 1

Kaye Edward M. MD · CIK 0001522780 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,302

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are fully vested from the moment of grant. Shares issued at per share price of $38.38, representing the Issuer's closing stock price on April 1, 2022.

Read SEC document
April 01, 2022 Filed Apr 1, 2022 23:16 UTC
Bhanji MunaDirector
GrantCommon Stock 293 $38.38 $11,245.34
Disclosure

SEC source: 0001061983-22-000086 · edgardoc.xml · nonDerivative · entry 1

Bhanji Muna · CIK 0001846905 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,537

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are fully vested from the moment of grant. Shares issued at per share price of $38.38, representing the Issuer's closing stock price on April 1, 2022.

Read SEC document
April 01, 2022 Filed Apr 1, 2022 23:17 UTC GrantCommon Stock 146 $38.38 $5,603.48
Disclosure

SEC source: 0001061983-22-000091 · edgardoc.xml · nonDerivative · entry 1

Wysenski Nancy · CIK 0001294596 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,149

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are fully vested from the moment of grant. Shares issued at per share price of $38.38, representing the Issuer's closing stock price on April 1, 2022.

Read SEC document
April 01, 2022 Filed Apr 1, 2022 23:17 UTC GrantCommon Stock 146 $38.38 $5,603.48
Disclosure

SEC source: 0001061983-22-000090 · edgardoc.xml · nonDerivative · entry 1

WIERENGA WENDALL · CIK 0001235945 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,033

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are fully vested from the moment of grant. Shares issued at per share price of $38.38, representing the Issuer's closing stock price on April 1, 2022.

Read SEC document
April 01, 2022 Filed Apr 1, 2022 23:17 UTC GrantCommon Stock 146 $38.38 $5,603.48
Disclosure

SEC source: 0001061983-22-000089 · edgardoc.xml · nonDerivative · entry 1

SMITH SANDFORD D · CIK 0001243004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,033

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are fully vested from the moment of grant. Shares issued at per share price of $38.38, representing the Issuer's closing stock price on April 1, 2022.

Read SEC document
April 01, 2022 Filed Apr 1, 2022 23:17 UTC GrantCommon Stock 488 $38.38 $18,729.44
Disclosure

SEC source: 0001061983-22-000087 · edgardoc.xml · nonDerivative · entry 1

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,562

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are fully vested from the moment of grant. Shares issued at per share price of $38.38, representing the Issuer's closing stock price on April 1, 2022.

Read SEC document
March 21, 2022 Filed Mar 23, 2022 21:30 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $7.96 $0.00
Disclosure

SEC source: 0001061983-22-000079 · edgardoc.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149,208

Underlying: Common Stock · 10,000 shares

Expires 2025-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
March 21, 2022 Filed Mar 23, 2022 21:30 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 10,000 $36.03 $360,342.00
Disclosure

SEC source: 0001061983-22-000079 · edgardoc.xml · nonDerivative · entry 2

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 409,124

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
March 21, 2022 Filed Mar 23, 2022 21:30 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 10,000 $7.96 $79,600.00
Disclosure

SEC source: 0001061983-22-000079 · edgardoc.xml · nonDerivative · entry 1

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 419,124

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
March 15, 2022 Filed Mar 15, 2022 23:34 UTC
SCHLOSSBERG MARK ASVP - Legal & General Counsel
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 25,196 $0.00 Strike: $14.40 $0.00
Disclosure

SEC source: 0001061983-22-000077 · edgardoc.xml · derivative · entry 7

SCHLOSSBERG MARK A · CIK 0001520533 · SVP - Legal & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,197

Underlying: Common Stock · 25,196 shares

Expires 2030-03-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 15, 2022 Filed Mar 15, 2022 23:34 UTC
SCHLOSSBERG MARK ASVP - Legal & General Counsel
Exercise / conversionIncentive Stock Option (right to buy) · Derivative 4,803 $0.00 Strike: $14.40 $0.00
Disclosure

SEC source: 0001061983-22-000077 · edgardoc.xml · derivative · entry 6

SCHLOSSBERG MARK A · CIK 0001520533 · SVP - Legal & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,804

Underlying: Common Stock · 4,803 shares

Expires 2030-03-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 15, 2022 Filed Mar 15, 2022 23:34 UTC
SCHLOSSBERG MARK ASVP - Legal & General Counsel
Exercise / conversionIncentive Stock Option (right to buy) · Derivative 30,818 $0.00 Strike: $7.03 $0.00
Disclosure

SEC source: 0001061983-22-000077 · edgardoc.xml · derivative · entry 5

SCHLOSSBERG MARK A · CIK 0001520533 · SVP - Legal & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,938

Underlying: Common Stock · 30,818 shares

Expires 2029-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 15, 2022 Filed Mar 15, 2022 23:34 UTC
SCHLOSSBERG MARK ASVP - Legal & General Counsel
SaleCommon Stock 25,196 $33.96 $855,724.19
Disclosure

SEC source: 0001061983-22-000077 · edgardoc.xml · nonDerivative · entry 4

SCHLOSSBERG MARK A · CIK 0001520533 · SVP - Legal & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,408

Read SEC document
March 15, 2022 Filed Mar 15, 2022 23:34 UTC
SCHLOSSBERG MARK ASVP - Legal & General Counsel
Exercise / conversionCommon Stock 25,196 $14.40 $362,822.40
Disclosure

SEC source: 0001061983-22-000077 · edgardoc.xml · nonDerivative · entry 3

SCHLOSSBERG MARK A · CIK 0001520533 · SVP - Legal & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,604

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 15, 2022 Filed Mar 15, 2022 23:34 UTC
SCHLOSSBERG MARK ASVP - Legal & General Counsel
Exercise / conversionCommon Stock 4,803 $14.40 $69,163.20
Disclosure

SEC source: 0001061983-22-000077 · edgardoc.xml · nonDerivative · entry 2

SCHLOSSBERG MARK A · CIK 0001520533 · SVP - Legal & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,408

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 15, 2022 Filed Mar 15, 2022 23:34 UTC
SCHLOSSBERG MARK ASVP - Legal & General Counsel
Exercise / conversionCommon Stock 30,818 $7.03 $216,650.54
Disclosure

SEC source: 0001061983-22-000077 · edgardoc.xml · nonDerivative · entry 1

SCHLOSSBERG MARK A · CIK 0001520533 · SVP - Legal & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,605

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 10, 2022 Filed Mar 11, 2022 00:42 UTC
Malik Fady IbrahamEVP Research & Development
Exercise / conversionIncentive Stock Option (right to buy) · Derivative 26,852 $0.00 Strike: $6.00 $0.00
Disclosure

SEC source: 0001061983-22-000075 · edgardoc.xml · derivative · entry 3

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 26,852 shares

Expires 2023-03-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.